BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15781686)

  • 1. Drug-induced eosinophilia and systemic symptoms: hypersensitivity or peripheral T-cell lymphoma?
    Schleinitz N; Veit V; Coso D; Aurran T; Berbis P; Harle JR
    Arch Dermatol; 2005 Mar; 141(3):395-6. PubMed ID: 15781686
    [No Abstract]   [Full Text] [Related]  

  • 2. A rare entity among childhood malignant lymphomas (large anaplastic T-cell Ki-1 +).
    Ulukutlu L; Hitzig W; Maurer R
    Turk J Pediatr; 1992; 34(1):37-41. PubMed ID: 1509528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma].
    Qin Y; Shi YK; He XH; Yang JL; Zhang CG; Zhou SY; Liu XF; Liu P; Yang S; Zhou LQ; Han XH; Yao JR
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):448-51. PubMed ID: 20819488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of peripheral T-cell lymphoma].
    Suzumiya J; Moriyama I; Kawakami K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case report of composite lymphoma].
    Wu J; Wang ZC; Chen XD
    Ai Zheng; 2007 Apr; 26(4):447. PubMed ID: 17430672
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Images in haematology. Irreversible blindness secondary to posterior reversible encephalopathy syndrome following CHOP combination chemotherapy.
    Hemmaway C; Mian A; Nagy Z
    Br J Haematol; 2010 Jul; 150(2):129. PubMed ID: 20487440
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
    He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
    Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-CHOP for mantle cell lymphoma.
    Klumpp TR
    J Clin Oncol; 2005 Sep; 23(27):6802; author reply 6802-3. PubMed ID: 16170194
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
    Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
    Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravascular B-cell lymphoma diagnosed by skin biopsy.
    Le K; Lim A; Bullpitt P; Wood G
    Australas J Dermatol; 2005 Nov; 46(4):261-5. PubMed ID: 16197428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic subcutaneous infiltration: an unusual presentation of subcutaneous panniculitis-like T-cell lymphoma.
    Ballanger F; Barbarot S; Le Gouill S; Gaillard F; Cassagnau E; Lodé L; Dréno B; Stalder JF
    Acta Derm Venereol; 2009; 89(4):427-9. PubMed ID: 19688166
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
    Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
    Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T-cell lymphoma, NOS, with rapidly progressing leukocytosis mimicking acute lymphoblastic leukemia.
    Jelinek T; Zuchnicka J
    Blood; 2020 May; 135(20):1816. PubMed ID: 32407530
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary cutaneous B-cell lymphoma: report of eight cases and review of the literature.
    Vural F; Saydam G; Cagirgan S; Ertekin B; Hekimgil M; Unal I; Soydan S; Tombuloglu M
    Int J Dermatol; 2008 Jul; 47(7):675-80. PubMed ID: 18613872
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term survival after nasal NK/T cell lymphoma].
    Rajnics P; Krenács L; Kenéz A; Járay Z; Bagdi E; Demeter J
    Orv Hetil; 2008 Apr; 149(17):801-5. PubMed ID: 18426762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual extranodal T-cell non-Hodgkin lymphoma.
    Coats JT; Mackie ADR; Kernohan NM; Ramkumar PG; McMahon LM; Goodlad JR; Tauro S
    Lancet; 2016 Sep; 388(10049):1127-1128. PubMed ID: 27628520
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV)-associated aggressive peripheral T-cell lymphoma showing folliculotropism.
    Choi HJ; Chang SE; Koh JK
    Int J Dermatol; 2006 May; 45(5):631-3. PubMed ID: 16700811
    [No Abstract]   [Full Text] [Related]  

  • 19. Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumor lysis in a patient with peripheral T-cell lymphoma unspecified.
    Hirata Y; Yokote T; Kobayashi K; Nakayama S; Miyoshi T; Akioka T; Tsuji M; Takubo T; Hanafusa T
    Leuk Lymphoma; 2009 Jul; 50(7):1226-9. PubMed ID: 19557646
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma.
    Alaibac M; Berti E; Pigozzi B; Chiarion V; Aversa S; Marino F; Peserico A
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S121-3. PubMed ID: 15858508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.